Adamas Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
85,612.00
122,358.00
106,395.00
113,652.00
172,842.00
210,370
Total Accounts Receivable
129.00
524.00
5,977.00
962.00
1,974.00
6,851
Inventories
-
-
-
-
1,704.00
5,121
Other Current Assets
267.00
645.00
815.00
2,373.00
2,655.00
6,031
Total Current Assets
86,008.00
123,527.00
113,187.00
116,987.00
179,175.00
228,373
Net Property, Plant & Equipment
199.00
1,228.00
2,353.00
3,156.00
3,132.00
3,652
Total Investments and Advances
-
36,364.00
13,129.00
22,192.00
2,977.00
-
Long-Term Note Receivable
-
-
36.00
100.00
14.00
-
Other Assets
9.00
70.00
38.00
38.00
878.00
2,789
Total Assets
86,216.00
161,189.00
128,743.00
142,473.00
186,176.00
234,814
Accounts Payable
2,097.00
3,685.00
3,052.00
3,589.00
3,878.00
Income Tax Payable
101.00
4,773.00
53.00
37.00
-
Other Current Liabilities
2,020.00
4,087.00
8,702.00
6,117.00
12,729.00
Total Current Liabilities
4,218.00
12,545.00
11,807.00
9,743.00
16,607.00
Long-Term Debt
-
-
-
-
102,647.00
Other Liabilities
6,244.00
1,570.00
749.00
547.00
796.00
Total Liabilities
10,462.00
14,115.00
12,556.00
10,290.00
120,050.00
Common Equity (Total)
56,605.00
147,074.00
116,187.00
132,183.00
66,126.00
Total Shareholders' Equity
75,754.00
147,074.00
116,187.00
132,183.00
66,126.00
Total Equity
75,754.00
147,074.00
116,187.00
132,183.00
66,126.00
Liabilities & Shareholders' Equity
86,216.00
161,189.00
128,743.00
142,473.00
186,176.00
Preferred Stock (Carrying Value)
19,149.00
-
-
-
-
About Adamas Pharmaceuticals
View Profile
